Brazil dengue: Government must invest in adequate water systems to reduce mosquito habitats Brazil dengue: Government must invest in adequate water systems to reduce mosquito habitats
Image/NIAID
The research was led by the London School of Hygiene & Tropical Medicine’s (LSHTM) Centre on Climate Change & Planetary Health and Centre for the Mathematical Modelling of Infectious Diseases. Using advanced statistical modelling techniques, the team predicted the timing and intensity of dengue risk in Brazil from extreme weather patterns.
The risk of dengue was high in urban areas three to five months after extreme drought. Extremely wet conditions increased dengue risk in the same month and up to three months later. In rural areas, dengue risk was more readily associated with very wet conditions.
LSHTM reacts to the death of its patron, His Royal Highness Prince Philip
LSHTM reacts to the death of its patron, His Royal Highness Prince Philip 9 April 2021 London School of Hygiene & Tropical Medicine London School of Hygiene & Tropical Medicine https://lshtm.ac.uk/themes/custom/lshtm/images/lshtm-logo-black.png
HRH Prince Philip was a great supporter of LSHTM’s work for almost 70 years Share
The London School of Hygiene & Tropical Medicine is deeply saddened to learn of the death of His Royal Highness Prince Philip, Duke of Edinburgh.
Prince Philip became LSHTM s patron in 1952 and made numerous visits to LSHTM, including during its centenary celebration in 1999. In more recent years, HRH hosted our closest supporters at Buckingham Palace.
Katherine E. Bliss, Senior Fellow and Project Director for the CSIS-LSHTM High-Level Panel, will provide opening remarks.
J. Stephen Morrison, Senior Vice President and Director of the CSIS Global Health Policy Center, will then moderate a panel discussion on the federal reforms needed to strengthen confidence in vaccines, including Covid-19 vaccines, in the United States. This expert panel will feature
Bruce Gellin, President of Global Immunization at the Sabin Vaccine Institute;
Margaret “Peggy” Hamburg, former Commissioner of the U.S. Food and Drug Administration and Interim Vice President of Global Biological Policy and Programs at the Nuclear Threat Initiative;
Juliette Kayyem, Senior Belfer Lecturer in International Security at Harvard’s Kennedy School of Government;
5 Min Read
(Reuters) -Europe’s drug regulator said on Friday it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson’s COVID-19 vaccine.
FILE PHOTO: A nurse draws from a vial of Johnson & Johnson coronavirus disease (COVID-19) vaccine, in Los Angeles, California, U.S., March 25, 2021. REUTERS/Lucy Nicholson/File Photo
The European Medicines Agency’s safety committee has also been looking at how AstraZeneca’s COVID-19 vaccine is associated with very rare cases of unusual blood clots and said it was now reviewing reports of capillary leak syndrome in people given AstraZeneca’s vaccine.
Study: Even short-term exposure to ambient CO levels can increase mortality news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.